Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma
Josephine Yates,Camille Mathey-Andrews,Jihye Park,Amanda Garza,Andreanne Gagne,Samantha E Hoffman,Kevin Bi,Breanna Titchen,Connor Hennessey,Joshua Remland,Erin E Shannon,Sabrina Camp,Siddhi Balamurali,Shweta Kiran Cavale,Zhixin Li,Akhouri Kishore Raghawan,Agnieszka Kraft,Genevieve Boland,Andrew J Aguirre,Nilay Sethi,Valentina Boeva,Eliezer Van Allen
DOI: https://doi.org/10.1101/2024.08.17.608386
2024-08-20
Abstract:Esophageal adenocarcinoma (EAC) is a highly lethal cancer of the upper gastrointestinal tract with rising incidence in western populations. To decipher EAC disease progression and therapeutic response, we performed multiomic analyses of a cohort of primary and metastatic EAC tumors, incorporating single-nuclei transcriptomic and chromatin accessibility sequencing, along with spatial profiling. We identified tumor microenvironmental features previously described to associate with therapy response. We identified five malignant cell programs, including undifferentiated, intermediate, differentiated, epithelial-to-mesenchymal transition, and cycling programs, which were associated with differential epigenetic plasticity and clinical outcomes, and for which we inferred candidate transcription factor regulons. Furthermore, we revealed diverse spatial localizations of malignant cells expressing their associated transcriptional programs and predicted their significant interactions with microenvironmental cell types. We validated our findings in three external single-cell RNA-seq and three bulk RNA-seq studies. Altogether, our findings advance the understanding of EAC heterogeneity, disease progression, and therapeutic response.
Cancer Biology